Startup manufacturing non-traumatic medical devices for gynecology
Aspivix has raised €4.8M across 1 funding round from 4 investors, most recently a Series A round in Nov 2022. Based in Renens, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-17 | Series A | €4.8M |
| 4FOx ventures,Hemex,LaunchPad APAC,Zürcher Kantonalbank |
| View deal → |
